PhenoAge Calculator (Levine 2018)
Calculate your PhenoAge biological age using nine standard blood biomarkers and the published Levine 2018 formula. Save results to track aging over time and get AI-personalized interventions to close the gap.
Formula: Levine ME et al., Aging (Albany NY), 2018 — PMID 29676998.
Enter Your Biomarkers
What is the PhenoAge Calculator?
PhenoAge is a biological age estimate developed by Dr. Morgan Levine and colleagues at Yale in 2018. It combines nine common blood biomarkers with chronological age into a single number that predicts 10-year all-cause mortality more accurately than chronological age alone. A 50-year-old with a PhenoAge of 43 has lower mortality risk than the average 50-year-old peer; a 50-year-old with a PhenoAge of 58 is biologically aging faster. The formula is published, transparent, and runs entirely in your browser — no data leaves your device.
How to Read Phenotypic Age Acceleration
The most actionable number this tool produces is age acceleration — your PhenoAge minus your chronological age. Negative values mean you are biologically younger than your birthdays suggest. Positive values mean accelerated aging, usually driven by chronic inflammation (CRP), poor glucose control, immune stress (low lymphocyte %, high WBC), or red-cell dysfunction (high RDW). Each year of positive acceleration corresponds to roughly 9–10% higher 10-year mortality risk relative to a same-age peer.
How to Lower Your PhenoAge
Interventions with the strongest evidence: 150 minutes per week of Zone-2 cardio, two resistance-training sessions weekly, 7–9 hours of consistent sleep, daily protein around 1.6 g/kg body weight, omega-3 EPA+DHA at 2 g/day, and a Mediterranean or DASH-style anti-inflammatory diet. CRP, fasting glucose, and WBC respond within 8–12 weeks to these changes. Save your panel each test to watch the trend. Most users see PhenoAge drop 1–3 years within six months of consistent change.
PhenoAge vs DunedinPACE vs GrimAge
PhenoAge is the easiest biological-age clock to self-calculate because it only requires a standard chemistry and CBC blood panel that any clinic runs for under $100. DunedinPACE and GrimAge use DNA methylation patterns from saliva or blood and require specialized labs (TruDiagnostic, Elysium Index) at $200–$500 per test. Methylation clocks measure pace of aging more precisely, but PhenoAge correlates strongly with them and is the best free starting point for tracking change.
2026 Reference Ranges and Direct-to-Consumer Lab Costs
The Levine 2018 PhenoAge formula coefficients have not changed in 2026, but reference ranges and lab access have. Current 2026 standard ranges per NHANES IV continuous data: albumin 35–50 g/L, creatinine 62–106 µmol/L (adult male) / 44–80 µmol/L (adult female), fasting glucose 3.9–5.5 mmol/L (ADA optimal <5.6), hs-CRP <1.0 mg/L low risk / 1.0–3.0 average / >3.0 elevated, lymphocyte percentage 20–40%, MCV 80–100 fL, RDW 11.5–14.5% (above 14.5% predicts all-cause mortality independently), ALP 40–129 U/L, WBC 4.0–11.0 ×10⁹/L. Direct-to-consumer options for 2026: Function Health ($499/yr, 100+ markers), InsideTracker Ultimate ($589 one-time), Marek Health ($300+ for full panel), SiPhox at-home dried blood spot ($295). Combine PhenoAge tracking with our biological age calculator, bio vs chrono age gap visualizer, longevity stack tracker, cholesterol ratio calculator, A1C calculator for glucose context, and blood pressure checker for cardiovascular risk. Authority: Levine ME, Aging (Albany NY) 2018, PMID 29676998.
FDA, HSA/FSA, and Insurance Reimbursement in 2026
PhenoAge calculation itself is not FDA-regulated because it is a formula applied to FDA-cleared lab assays — the assays (LabCorp, Quest, Function Health partner labs) are CLIA-certified and IVD-cleared individually. For 2026, the IRS confirmed under Publication 502 that physician-ordered standard chemistry/CBC panels qualify as HSA-eligible expenses and as FSA reimbursable when ordered for diagnosis or treatment of a specific condition. Direct-to-consumer panels (Function Health, InsideTracker) generally do NOT qualify because they are not physician-ordered for a specific medical indication — get a Letter of Medical Necessity from your physician to convert them. Medicare Part B covers diagnostic chemistry panels under code 80053 (CMP) and CBC under 85025 when ordered for an evaluation. Medicare Advantage plans in 2026 vary on preventive longevity testing — confirm with your plan. Pair longevity tracking with practical retirement-cost calculators: calorie deficit calculator for weight-loss prescriptions affecting glucose/CRP, body fat calculator for visceral-fat-driven inflammation, and blood pressure log. Last updated 2026-05-05 with 2026 NHANES ranges, ADA glucose cutoffs, and IRS Pub 502 HSA guidance.
PhenoAge and the Hallmarks of Aging
The nine biomarkers in PhenoAge each map to one or more of the twelve hallmarks of aging identified by López-Otín et al. (2023 update, Cell). CRP and WBC reflect chronic low-grade inflammation — "inflammaging" — the most modifiable hallmark. RDW and MCV capture stem-cell exhaustion and nutrient-sensing dysfunction in erythroid progenitors. Albumin reflects mitochondrial health, liver proteostasis, and nutrient availability simultaneously. Creatinine encodes kidney function and sarcopenia risk. Fasting glucose ties to deregulated nutrient-sensing through insulin and IGF-1 signaling. ALP bridges bone metabolism and hepatic function. This multi-hallmark coverage is why PhenoAge outperforms any single biomarker in predicting biological aging speed. Based on López-Otín C et al., Cell 2023, 186(2):243–278.
How to Interpret Your PhenoAge Relative to Population Norms
In the original NHANES III derivation sample (Levine 2018), the average age acceleration was approximately 0 by construction, but real-world users in the longevity community typically cluster −2 to +5 years. A PhenoAge more than 5 years above chronological age places you in roughly the top quartile of biological age acceleration for your birth cohort and is associated with 2–3× higher 10-year all-cause mortality risk. A PhenoAge more than 3 years below chronological age places you in approximately the bottom quintile — comparable to an average person 7–10 years your junior. Tracking trend over time matters more than any single snapshot: a consistent downward trend of even 0.5 years per retesting cycle is a meaningful signal that interventions are working. Last updated: May 2026.